TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
CGEN

Compugen

Healthcare · Biotechnology

2.30$ -2.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow CGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-90.1% -276.0% -2,783.6% – -74.7% – -1,416.0% -378.2% -454.8% -107.3% 178.0% 43.5%
5.3% 11.9% 208.4% – 7.8% – 35.8% 7.7% 6.4% 1.4% 1.7% 0.7%
29.4% 40.7% 433.1% – 12.2% – 138.6% 71.3% 57.7% 10.6% 10.8% 2.6%
11.5% 33.1% 393.5% – 12.7% – 147.2% 69.5% 56.8% – – –
-17.2% -103.7% 1,039.5% – 31.7% – -114.1% 113.7% -74.0% -61.9% 222.7% -7.3%
15.3% 33.6% 365.0% – 0.9% – 8.3% 4.9% 6.5% 0.5% 0.4% 0.4%
-518.2% 105.3% 2,288.3% – -197.5% – -4,108.6% 110.3% 494.1% 106.1% -166.0% 41.2%
583.2% 10.5% 345.2% – 159.5% – – – – – – –
583.2% 10.5% 345.2% – 159.5% – 5,423.2% 280.6% 4.7% 9.2% 2.0% 14.6%
-25.1% -160.2% -150.0% – -112.7% – -101.4% 11.7% 38.8% 8.5% 14.3% 99.5%
-105.5% -309.7% -3,148.6% – -75.6% – -1,424.3% -383.0% -461.3% -107.8% 177.6% 43.1%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?